£65.14

CARCINOMA DEL POLMONE

Price data last checked 22 day(s) ago - will refresh soon

View at Amazon

We'll watch every seller, every day. One email when your price arrives.

This is the most expensive it has ever been. Walk away.

£65 today · previous high £65 · all-time low £60

NEW HERE?

Amazon shows you one price. We show you all of them.

Tosheroon watches Amazon prices so you don't have to. Every product on Amazon has a price history — we make it visible. Set the price you'd actually pay, and we'll email you the second it gets there. No app, no account, one email.

WHAT'S ON THIS PAGE

↓ Price chart
when this has been cheap or pricey
↓ Forecast
where the price is heading next
↓ Statistics
all-time high & low, recent range
↑ Price alert
name your number, we'll email you

Price History & Forecast

Grey patches = out of stock. Cheaper = lower on the chart. Hover for exact prices.

Last 69 days · 69 data points (no recent data)

Historical
Generating forecast…
£65.14 £59.90 £61.05 £62.19 £63.33 £64.47 £65.62 09 July 2026 26 July 2026 12 August 2026 29 August 2026 15 September 2026

Price Distribution

Price distribution over 69 days • 2 price levels

Days at Price
Current Price
67 days 2 days · current 0 17 34 50 67 £60 £65 Days at Price

Price Analysis

Most common price: £60 (67 days, 97.1%)

Price range: £60 - £65

Price levels: 2 different prices over 69 days

Description

Il carcinoma del polmone è una delle principali cause di morte per tumore a livello globale e rappresenta non solo una sfida clinico-terapeutica, ma anche un grave problema socioeconomico. Gli stili di vita errati e l’inquinamento atmosferico sono le cause principali del carcinoma del polmone. In Italia i dati epidemiologici restano allarmanti. Secondo quanto riportato dall’AIRTUM e dall’AIOM (dicembre 2023), il carcinoma del polmone rappresenta nel 2023 circa il 14% delle diagnosi di tumore negli uomini e il 7,4% nelle donne, attestandosi globalmente tra i due sessi come terzo tumore con più di 35.000 nuovi casi e con una incidenza in crescita. Dietro ogni statistica si nascondono storie di vita, diverse terapie, speranze infrante e tanto dolore. Purtroppo viviamo in un periodo in cui il tecnofeudalesimo e le multinazionali petrolchimiche stanno inquinando il pianeta e danneggiando la salute dei suoi abitanti.

Product Specifications

Format
paperback
Domain
Amazon UK
Release Date
26 January 2026
Listed Since
27 January 2026

Barcode

No barcode data available

Similar Products You Might Like

Lung Cancer: Basic and Clinical Aspects: Basic and Clinical Aspects: 28 (Cancer Treatment and Research)
77% match

Lung Cancer: Basic and Clinical Aspects: Basic and Clinical Aspects: 28 (Cancer Treatment and Research)

Springer

£129.97 08 Aug 2026
Lung Cancer: Basic and Clinical Aspects: Basic and Clinical Aspects: 28 (Cancer Treatment and Research, 28)
76% match

Lung Cancer: Basic and Clinical Aspects: Basic and Clinical Aspects: 28 (Cancer Treatment and Research, 28)

Springer

£124.47 15 Sep 2026
Management des Lungenkarzinoms (Onkologie aktuell)
75% match

Management des Lungenkarzinoms (Onkologie aktuell)

Springer

£76.48 14 Sep 2026
Lung Cancer Metastasis: Novel Biological Mechanisms and Impact on Clinical Practice
75% match

Lung Cancer Metastasis: Novel Biological Mechanisms and Impact on Clinical Practice

Springer

£80.67 05 Aug 2026
Progress and Perspective in the Treatment of Lung Cancer (Medical Radiology)
75% match

Progress and Perspective in the Treatment of Lung Cancer (Medical Radiology)

Springer

£108.01 07 Aug 2026
The Molecular Genetics of Lung Cancer
75% match

The Molecular Genetics of Lung Cancer

Springer

£80.67 29 Jul 2026
Inflammation and Lung Cancer
74% match

Inflammation and Lung Cancer

Springer

£58.70 20 Aug 2026
Research Focus on Smoking and Women's Health
74% match

Research Focus on Smoking and Women's Health

Nova Science Publishers Inc

£68.82 08 Aug 2026
Cancer of the Lung: From Molecular Biology to Treatment Guidelines (Current Clinical Oncology)
74% match

Cancer of the Lung: From Molecular Biology to Treatment Guidelines (Current Clinical Oncology)

Humana

£108.01 06 Aug 2026
Molecular Targeted Therapy of Lung Cancer
73% match

Molecular Targeted Therapy of Lung Cancer

Springer

£113.79 08 Aug 2026
Biology and Management of Lung Cancer: 11 (Cancer Treatment and Research)
73% match

Biology and Management of Lung Cancer: 11 (Cancer Treatment and Research)

Springer

£169.56 06 Aug 2026
Management of Lung Cancer in Older People
73% match

Management of Lung Cancer in Older People

Springer

£80.67 04 Aug 2026
Management of Lung Cancer in Older People
73% match

Management of Lung Cancer in Older People

Springer

£103.27 04 Aug 2026
Non-Small Cell Lung Cancer: New Research (Cancer Etiology, Diagnosis and Treatments)
73% match

Non-Small Cell Lung Cancer: New Research (Cancer Etiology, Diagnosis and Treatments)

£66.33 05 Aug 2026
Lung Cancer, An Issue of Hematology/Oncology Clinics of North America: Volume 37-3 (The Clinics: Internal Medicine, Volume 37-3)
72% match

Lung Cancer, An Issue of Hematology/Oncology Clinics of North America: Volume 37-3 (The Clinics: Internal Medicine, Volume 37-3)

Elsevier

£72.22 08 Aug 2026
Opportunities, Risks, and Future Directions of AI in Pulmonary Medicine
72% match

Opportunities, Risks, and Future Directions of AI in Pulmonary Medicine

£142.50 14 Sep 2026
Targeted Therapies for Lung Cancer (Current Cancer Research)
72% match

Targeted Therapies for Lung Cancer (Current Cancer Research)

Springer

£92.22 05 Aug 2026
Malignant Mesothelioma
72% match

Malignant Mesothelioma

£54.50 16 Sep 2026
A Quick Guide to Cancer Epidemiology (SpringerBriefs in Cancer Research)
72% match

A Quick Guide to Cancer Epidemiology (SpringerBriefs in Cancer Research)

Springer

£48.90 06 Aug 2026
Methods of Cancer Diagnosis, Therapy, and Prognosis: General Overviews, Head and Neck Cancer and Thyroid Cancer: 7
72% match

Methods of Cancer Diagnosis, Therapy, and Prognosis: General Overviews, Head and Neck Cancer and Thyroid Cancer: 7

Springer

£155.27 31 Aug 2026
Risk and Progression Factors in Carcinogenesis: 143 (Recent Results in Cancer Research, 143)
72% match

Risk and Progression Factors in Carcinogenesis: 143 (Recent Results in Cancer Research, 143)

Springer

£78.01 04 Aug 2026
Pulmonary Health and Disorders: 1150 (Advances in Experimental Medicine and Biology, 1150)
71% match

Pulmonary Health and Disorders: 1150 (Advances in Experimental Medicine and Biology, 1150)

Springer

£76.42 07 Aug 2026
Malattie dell'apparato respiratorio
71% match

Malattie dell'apparato respiratorio

Springer

£81.74 08 Aug 2026
Genetic Susceptibility to Cancer: 79 (Developments in Oncology, 79)
71% match

Genetic Susceptibility to Cancer: 79 (Developments in Oncology, 79)

Springer

£76.42 08 Aug 2026